VIZIENT INC

Medicare/Medicaid

21st Century Cures Act: Establishment of Disincentives for Health Care Providers That Have Committed Information Blocking Proposed Rule - Urged CMS to refrain from finalizing the Proposed Rule. Encouraged CMS, ONC and OIG to provide additional clarity regarding several policies under consideration. Contract Year 2025 Policy and Technical Changes To The Medicare Advantage (MA Or Part C) and Medicare Prescription Drug Benefit (Part D) programs Proposed Rule - Encouraged CMS to consider the Vizient Vulnerability Index as the agency considers other potential social risk factors and urged CMS to continue monitoring patients out-of-pocket costs as formulary changes occur. Issues related to hospital and provider payment. Issues related to pharmacy benefit managers; monitoring the Modernizing and Ensuring PBM Accountability (MEPA) Act (S.2973). Lower Costs, More Transparency Act (H.R. 5378) - Opposed adoption of site-neutral payment policies for drug administration and increased fines related to price transparency requirements for hospitals. Urged Congress to redirect its focus from site-neutral payment policies to reducing administrative burdens and increasing, rather than reducing, payments for care delivery in rural areas. Medicaid Disproportionate Hospital (DSH) payment cuts - Urged Congress to avoid Medicaid Disproportionate Share Hospital (DSH) payment cuts scheduled to begin in FY 2024. Supported temporary delay of Medicaid DSH cuts in Consolidated Appropriations Act, 2024 (H.R. 4366). Medicare-supported Graduate Medical Education - Supported passage of the Resident Physician Shortage Reduction Act (H.R. 2389/S. 1302). The Medicare Dependent Hospital (MDH) program and the Low Volume Hospital Payment Adjustment (LVA) - Supported passage of the Assistance for Rural Community Hospitals (ARCH) Act (H.R 6430).

TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS)